Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLCO1B1 polymorphism and pitavastatin effects on repaglinide pharmacokinetics in healthy Chinese volunteers
ChiCTR-TRC-11001742Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of repaglinide and pitavastatin (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Repaglinide plasma concentration. Started Feb 2009; status: completed.
02
Drugs
repaglinidepitavastatin
Beyond the preview
Go deeper on ChiCTR-TRC-11001742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001742.